Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNASE1 | P07998 | 1/20 | 0.46 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.43 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.43 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.43 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | BCHE | P06276 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8815309 | 0.82 | LGALS9 (0.46) | RNASE1LGALS9LGALS1LGALS3LGALS7; LGALS7B | |
| SCHEMBL13274766 | 0.77 | RNASE1 (0.42) | RNASE1LGALS9LGALS1LGALS3LGALS7; LGALS7B | |
| SCHEMBL13274194 | 0.77 | RNASE1 (0.42) | RNASE1LGALS9LGALS1LGALS3LGALS7; LGALS7B | |
| SCHEMBL18271850 | 0.76 | RNASE1 (0.53) | RNASE1LGALS9LGALS1LGALS3LGALS7; LGALS7B | |
| SCHEMBL8811566 | 0.75 | LGALS9 (0.47) | RNASE1LGALS9LGALS1LGALS3LGALS7; LGALS7B | |
| SCHEMBL8811557 | 0.75 | LGALS9 (0.50) | RNASE1LGALS9LGALS1LGALS3LGALS7; LGALS7B | |
| SCHEMBL8811559 | 0.75 | LGALS9 (0.47) | RNASE1LGALS9LGALS1LGALS3LGALS7; LGALS7B | |
| SCHEMBL19020474 | 0.75 | RNASE1 (0.43) | RNASE1LGALS9LGALS1LGALS3LGALS7; LGALS7B | |
| SCHEMBL9469882 | 0.75 | LGALS9 (0.46) | LGALS9LGALS1LGALS3LGALS7; LGALS7BRAB9A | |
| SCHEMBL13396710 | 0.73 | RNASE1 (0.52) | RNASE1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6884880-B2 | Process for the preparation of 9-β-anomeric nucleoside analogs | ASH STEVENS, INC. (US) | 2005-04-26 | — | — | US | disclosed |
| US-20040039190-A1 | Process for the preparation of 9-beta-anomeric nucleoside analogs | ASH STEVENS, INC. | 2004-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040039190-A1 | Process for the preparation of 9-beta-anomeric nucleoside analogs | DPYD, SLC29A2, GALE | RNASE1 426/4885LGALS9 367/4885LGALS1 1135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.